CORTESE, ROSA
 Distribuzione geografica
Continente #
EU - Europa 2.244
NA - Nord America 1.819
AS - Asia 1.678
SA - Sud America 428
AF - Africa 117
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.292
Nazione #
US - Stati Uniti d'America 1.768
IT - Italia 664
SG - Singapore 589
RU - Federazione Russa 506
CN - Cina 394
BR - Brasile 355
IE - Irlanda 324
VN - Vietnam 170
HK - Hong Kong 162
GB - Regno Unito 152
FR - Francia 129
SE - Svezia 120
KR - Corea 93
DE - Germania 90
ZA - Sudafrica 72
FI - Finlandia 67
IN - India 67
BD - Bangladesh 61
ES - Italia 61
NL - Olanda 47
CA - Canada 30
AR - Argentina 22
TR - Turchia 20
IQ - Iraq 18
PL - Polonia 16
IR - Iran 14
KE - Kenya 14
AT - Austria 13
CH - Svizzera 13
EC - Ecuador 12
ID - Indonesia 12
PK - Pakistan 12
MX - Messico 11
UA - Ucraina 11
JP - Giappone 10
SA - Arabia Saudita 10
CL - Cile 9
CO - Colombia 9
CI - Costa d'Avorio 7
TN - Tunisia 7
UZ - Uzbekistan 7
HU - Ungheria 6
BE - Belgio 5
JO - Giordania 5
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
VE - Venezuela 5
AU - Australia 4
BO - Bolivia 4
LT - Lituania 4
NG - Nigeria 4
PH - Filippine 4
AL - Albania 3
DZ - Algeria 3
EG - Egitto 3
LB - Libano 3
MN - Mongolia 3
OM - Oman 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
KH - Cambogia 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 6.292
Città #
Dallas 329
Dublin 300
Singapore 284
Santa Clara 232
San Jose 188
Hong Kong 153
Ashburn 152
Hefei 142
Moscow 135
Southend 95
Seoul 92
Milan 84
Siena 84
Beijing 83
Johannesburg 63
Ho Chi Minh City 62
Los Angeles 60
Council Bluffs 52
Chandler 49
Málaga 44
Helsinki 41
Lauterbourg 40
Rome 40
New York 37
Hanoi 36
São Paulo 34
Munich 31
Princeton 31
Florence 30
Buffalo 27
Fairfield 23
Bengaluru 22
Houston 16
Pisa 16
San Francisco 16
Chicago 15
Lappeenranta 15
The Dalles 15
Frankfurt am Main 14
Redondo Beach 14
Cambridge 13
Nuremberg 13
Seattle 13
Belo Horizonte 12
Boston 12
Naples 12
Sarzana 12
Warsaw 12
Bari 11
Livorno 11
London 11
Phoenix 11
Reggio Emilia 11
Wilmington 11
Chennai 10
Haiphong 10
Lucca 10
Manchester 10
Montreal 10
Salvador 10
Woodbridge 10
Amsterdam 9
Baghdad 9
Orem 9
Rio de Janeiro 9
Carlentini 8
Fremont 8
Porto Alegre 8
Tokyo 8
Turin 8
Turku 8
Abidjan 7
Dhaka 7
Dong Ket 7
Hải Dương 7
Shanghai 7
Tashkent 7
Atlanta 6
Boardman 6
Bologna 6
Brasília 6
Brooklyn 6
Campinas 6
Denver 6
Hangzhou 6
Sacramento 6
Salt Lake City 6
San Diego 6
Tehran 6
Verona 6
Amman 5
Brussels 5
Columbus 5
Falkenstein 5
Genoa 5
Gyomro 5
Istanbul 5
Mexico City 5
Monsummano Terme 5
Pescara 5
Totale 3.685
Nome #
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 298
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 240
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 200
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 197
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 188
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 173
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 171
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 156
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 144
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 139
Uveitis: A snapshot in the MOG antibody spectrum 137
MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease 134
FOLR1 Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years 132
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 131
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 127
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging 126
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 125
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets 124
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis 124
Establishment of a clinician-led guideline on the diagnosis and treatment of Hirayama disease using a modified Delphi technique 118
BIANCA-MS: An optimized tool for automated multiple sclerosis lesion segmentation 117
Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD 117
Cerebrospinal fluid neurofilament light chain levels: Marker of progression to generalized amyotrophic lateral sclerosis 116
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy 114
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique 112
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 111
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis 110
Gender Inequities in the Multiple Sclerosis Community: A Call for Action 110
Vessel-CAPTCHA: An efficient learning framework for vessel annotation and segmentation 107
Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio 107
High-dimensional detection of imaging response to treatment in multiple sclerosis 104
Editorial: Cognition in Multiple Sclerosis 104
Evaluation of cervical spinal cord atrophy using a modified SIENA approach 103
Fatigue in multiple sclerosis: The role of thalamus 103
Advances in brain imaging in multiple sclerosis 101
Magnetic resonance imaging evidence supporting the efficacy of cladribine tablets in the treatment of relapsing-remitting multiple sclerosis 100
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 100
Structural and functional connectivity substrates of cognitive impairment in multiple sclerosis 97
Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis (npj Digital Medicine, (2019), 2, 1, (49), 10.1038/s41746-019-0127-8) 97
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging – Yes 96
Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis 94
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study 90
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis 90
Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know? 88
Primary progressive multiple sclerosis presenting under the age of 18 years: Fact or fiction? 88
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 84
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: A possible marker of disease severity and progression 79
Guiding differentiation of non-acute MOGAD from AQP4-NMOSD and RRMS using clinical and MRI measures 71
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 70
Amyotrophic lateral sclerosis: A new missense mutation in the SOD1 gene 67
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 64
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 48
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP) 43
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 37
The role of imaging in Hirayama disease 31
Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal 27
Neurophysiological, imaging and neurobiological markers of central fatigue in multiple sclerosis 26
Hirayama disease: the importance of an early diagnosis 26
Linking movement-related beta oscillations to cortical excitability, structural damage, and fatigue in multiple sclerosis 21
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody–Associated Disease 7
Clinically Relevant Patterns of Co‐Fluctuating Structure and Function in Multiple Sclerosis 6
MRI in multiple sclerosis: progress in in-vivo pathobiology 6
Totale 6.473
Categoria #
all - tutte 25.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.267


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022227 4 1 3 2 3 6 2 1 83 9 52 61
2022/2023528 25 36 78 47 20 86 71 41 47 46 14 17
2023/2024453 12 14 37 18 10 109 175 13 6 12 5 42
2024/20251.653 47 67 145 95 211 83 83 107 145 95 171 404
2025/20263.436 303 460 352 410 549 87 381 133 136 246 281 98
Totale 6.473